Noble Partners as of June 30, 2011
Portfolio Holdings for Noble Partners
Noble Partners holds 26 positions in its portfolio as reported in the June 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Golar Lng Partners Lp unit | 28.9 | $9.5M | 332k | 28.50 | |
| Amarin Corporation | 9.3 | $3.0M | 210k | 14.43 | |
| Elan Corporation | 8.5 | $2.8M | 245k | 11.37 | |
| Akorn | 8.0 | $2.6M | 375k | 7.00 | |
| Gilead Sciences (GILD) | 6.3 | $2.1M | 50k | 41.42 | |
| Allergan | 5.1 | $1.7M | 20k | 83.25 | |
| United States Natl Gas Fund opt | 3.4 | $1.1M | 100k | 11.02 | |
| Perrigo Company | 3.2 | $1.1M | 12k | 87.83 | |
| Volcano Corporation | 2.5 | $807k | 25k | 32.28 | |
| CIGNA Corporation | 2.4 | $771k | 15k | 51.40 | |
| CVS Caremark Corporation (CVS) | 2.3 | $767k | 20k | 37.60 | |
| Watson Pharmaceuticals | 2.3 | $756k | 11k | 68.73 | |
| Alexion Pharmaceuticals | 2.1 | $705k | 15k | 47.00 | |
| Bristol Myers Squibb (BMY) | 1.8 | $579k | 20k | 28.95 | |
| Cardiome Pharma Corp | 1.7 | $556k | 125k | 4.45 | |
| Banro Corp | 1.7 | $556k | 147k | 3.79 | |
| Gen-Probe Incorporated | 1.7 | $553k | 8.0k | 69.12 | |
| WellPoint | 1.4 | $473k | 6.0k | 78.83 | |
| Ariad Pharmaceuticals | 1.4 | $453k | 40k | 11.32 | |
| Lincare Holdings | 1.3 | $439k | 15k | 29.27 | |
| Jazz Pharmaceuticals | 1.2 | $400k | 12k | 33.33 | |
| Stealthgas (GASS) | 1.2 | $388k | 91k | 4.28 | |
| Cerner Corporation | 0.8 | $244k | 4.0k | 61.00 | |
| Insulet Corporation (PODD) | 0.7 | $222k | 10k | 22.20 | |
| Hologic (HOLX) | 0.6 | $202k | 10k | 20.20 | |
| ACADIA Pharmaceuticals (ACAD) | 0.2 | $65k | 40k | 1.62 |
